Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 269 papers

Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis

Gustot T, Fernandez J, Garcia E, Morando F, Caraceni P, Alessandria C, Laleman W, Trebicka J, Elkrief L, Hopf C, Solís-Munoz P, Saliba F, Zeuzem S, Albillos A, Benten D, Montero-Alvarez JL, Chivas MT, Concepción M, Córdoba J, McCormick A, Stauber R, Vogel W, de Gottardi A, Welzel TM, Domenicali M, Risso A, Wendon J, Deulofeu C, Angeli P, Durand F, Pavesi M, Gerbes A, Jalan R, Moreau R, Ginés P, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL-CLIF Consortium.

Hepatology 2015, 62(1): 243–52

DOI: 10.1002/hep.27849

Extracorporeal liver support and liver transplantation for acute-on-chronic liver failure

Ballester MP, Elshabrawi A, Jalan R.

Liver Int 2023

DOI: 10.1111/liv.15647

Roles of systemic inflammatory and metabolic responses in the pathophysiology of acute-on-chronic liver failure

Clària J, Arroyo V, Moreau R.

JHEP Rep 2023, 5(9):100807

DOI: 10.1016/j.jhepr.2023.100807

Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure

Schierwagen R, Gu W, Brieger A, Brüne B, Ciesek S, Đikić I, Dimmeler S, Geisslinger G, Greten FR, Herrmann E, Hildt E, Kempf VAJ, Klein S, Koch I, Mühl H, Müller V, Peiffer KH, Kestner RI, Piiper A, Rohde G, Scholich K, Schulz MH, Storf H, Toptan T, Vasa-Nicotera M, Vehreschild MJGT, Weigert A, Wild PJ, Zeuzem S, Engelmann C; ACLF-I investigators; Schaefer L, Welsch C, Trebicka J.

Am J Physiol Cell Physiol 2023

DOI: 10.1152/ajpcell.00101.2023

Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis

Ballester MP, Tranah TH, Balcar L, Fiorillo A, Ampuero J, Kerbert AJC, Thomsen KL, Escudero MD, Mandorfer M, Reiberger T, Shawcross DL, Romero-Gómez M, Montoliu C, Carbonell-Asins JA, Jalan R.

J Hepatol 2023, S0168-8278(23)00351-3

DOI: 10.1016/j.jhep.2023.05.022

Sphingolipids are depleted in alcohol-related liver fibrosis

Thiele M, Suvitaival T, Trošt K, Kim M, de Zawadzki A, Kjaergaard M, Rasmussen DN, Lindvig KP, Israelsen M, Detlefsen S, Andersen P, Juel HB, Nielsen T, Georgiou S, Filippa V, Kuhn M, Nishijima S, Moitinho-Silva L, Rossing P, Trebicka J, Anastasiadou E, Bork P, Hansen T, Legido-Quigley C, Krag A; MicrobLiver Consortium; GALAXY Consortium.

Gastroenterology 2023, 164(7): 1248–1260

DOI: 10.1053/j.gastro.2023.02.023

Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure

Agarwal B, Cañizares RB, Saliba F, Ballester MP, Tomescu DR, Martin D, Stadlbauer V, Wright G, Sheikh M, Morgan C, Alzola C, Lavin P, Green D, Kumar R, Sacleux SC, Schilcher G, Koball S, Tudor A, Minten J, Domenech G, Aragones JJ, Oettl K, Paar M, Waterstradt K, Bode-Boger SM, Ibáñez-Samaniego L, Gander A, Stange J, Lamprecht G, Sanchez M, Mookerjee RP, Davenport A, Davies N, Pavesi M, Andreola F, Albillos A, Cordingley J, Schmidt H, Carbonell-Asins JA, Arroyo V, Fernandez J, Mitzner S, Jalan R.

J Hepatol 2023, 79(1): 79–92

DOI: 10.1016/j.jhep.2023.03.013

Genetic ancestry, race, and severity of acutely decompensated cirrhosis in Latin America

Farias AQ, Curto Vilalta A, Zitelli PM, Pereira G, Goncalves LL, Torre A, Diaz JM, Gadano AC, Mattos AZ, Mendes LSC, Alvares-da-Silva MR, Bittencourt PL, Benitez C, Couto CA, Mendizabal M, Toledo CL, Mazo DF, Barradas MC, Uson Raposo EM, Padilla-Machaca PM, Lozano Miranda AZ, Malé-Velázquez R, Lyra AC, Dávalos-Moscol MB, Pérez Hernandez JL, Ximenes RO, Silva GF, Beltrán-Galvis OA, González Huezo MS, Bessone F, Rocha TDS, Fassio E, Terra C, Marín JI, Casas PS, Peña-Ramirez C, Parera FA, Fernandes F, da Penha Zago-Gomes M, Méndez-Guerrero O, Marciano S, Mattos AA, Oliveira JC, Guerreiro GTS, Codes L, Arrese M, Nardelli MJ, Silva MO, Palma-Fernandez R, Alcantara C, Sánchez Garrido C, Trebicka J, Gustot T, Fernández J, Clària J, Jalan R, Angeli P, Arroyo V, Moreau R, Carrilho FJ; ACLARA Study collaborators.

Gastroenterology 2023, 30:S0016-5085(23)00806-5

DOI: 10.1053/j.gastro.2023.05.033

Endoscopic advances in hepatology

Vanderschueren E, Trebicka J, Laleman W.

Semin Liver Dis 2023

DOI: 10.1055/s-0043-1769009

The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis

Reiberger T, Berzigotti A, Trebicka J, Ertle J, Gashaw I, Swallow R, Tomisser A.

Trials 2023, 24(1): 293

DOI: 10.1186/s13063-023-07291-3